Clinical Trial

Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) for Resectable Locally Advanced Gastric Cancer

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated December 30, 2024 (before its estimated June 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
To evaluate efficacy and safety of Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (PLOF) in resectable locally advanced gastric cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-09-22.
Trial Details
NCT Number NCT06054906
Lead Sponsor Huashan Hospital
Conditions Gastric Cancer
Enrollment 50 participants
Start Date 2023-10-18
Primary Completion 2025-06-30 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-12-30